US Stocks Focus

Apollo HealthCo Limited, a subsidiary of Apollo Hospitals Enterprise Limited, has entered into a binding agreement to raise equity capital of ₹2,475 crore from Advent International, one of the world’s largest and most experienced global private equity investors. In addition, Apollo 24/7 has entered into a framework agreement to integrate 100% of Keimed Private Limited, India’s leading wholesale pharma distributor, in a phased manner over the next 24-30 months.

Apollo HealthCo Limited, a subsidiary of Apollo Hospitals Enterprise Limited, has entered into a binding agreement to raise equity capital of ₹2,475 crore from Advent International, one of the world’s largest and most experienced global private equity investors. In addition, Apollo 24/7 has entered into a framework agreement to integrate 100% of Keimed Private Limited, India’s leading wholesale pharma distributor, in a phased manner over the next 24-30 months.

Apollo HealthCo Limited, a subsidiary of Apollo Hospitals Enterprise Limited, has entered into a binding agreement to raise equity capital of ₹2,475 crore from Advent International, one of the world’s largest and most experienced global private equity investors. In addition, Apollo 24/7 has entered into a framework agreement to integrate 100% of Keimed Private Limited, India’s leading wholesale pharma distributor, in a phased manner over the next 24-30 months.

Apollo HealthCo Limited, a subsidiary of Apollo Hospitals Enterprise Limited, has entered into a binding agreement to raise equity capital of ₹2,475 crore from Advent International, one of the world’s largest and most experienced global private equity investors. In addition, Apollo 24/7 has entered into a framework agreement to integrate 100% of Keimed Private Limited, India’s leading wholesale pharma distributor, in a phased manner over the next 24-30 months.

Apollo HealthCo Limited, a subsidiary of Apollo Hospitals Enterprise Limited, has entered into a binding agreement to raise equity capital of ₹2,475 crore from Advent International, one of the world’s largest and most experienced global private equity investors. In addition, Apollo 24/7 has entered into a framework agreement to integrate 100% of Keimed Private Limited, India’s leading wholesale pharma distributor, in a phased manner over the next 24-30 months.

Apollo HealthCo Limited, a subsidiary of Apollo Hospitals Enterprise Limited, has entered into a binding agreement to raise equity capital of ₹2,475 crore from Advent International, one of the world’s largest and most experienced global private equity investors. In addition, Apollo 24/7 has entered into a framework agreement to integrate 100% of Keimed Private Limited, India’s leading wholesale pharma distributor, in a phased manner over the next 24-30 months.

Target: ₹1,995

Target: ₹3,000

CSI Intelligent Financial Information Lyle Technology (688683) disclosed its first quarter report for 2024 on April 26. In the first quarter of 2024, the company achieved total operating income of 99.5788 million yuan, a year-on-year increase of 9.05%; net profit attributable to the parent company was 8.3337 million yuan, a year-on-year increase of 3.65%; non-net profit after deducting 6.6039 million yuan, a year-on-year increase of 4.54%; generated from operating activities Net cash flow was 4.024 million yuan, a year-on-year decrease of 68.80%; during the reporting period, Lyle Technology\’s basic earnings per share was 0.05 yuan, and the weighted average return on net assets was 0.83%.

Gelonghui April 25丨Martian (300894.SZ) announced the first quarter report of 2024. The operating income during the reporting period was 348 million yuan, a year-on-year decrease of 15.44%; the net profit attributable to shareholders of the listed company was 36.8823 million yuan, a year-on-year decrease of 24.52%. %; net profit after non-recurring gains and losses attributable to shareholders of listed companies was 33.8044 million yuan, a year-on-year decrease of 18.07%; basic earnings per share was 0.09 yuan.